Page last updated: 2024-08-21

tristearin and Experimental Mammary Neoplasms

tristearin has been researched along with Experimental Mammary Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bendayan, R; Rauth, AM; Wong, HL; Wu, XY1

Other Studies

1 other study(ies) available for tristearin and Experimental Mammary Neoplasms

ArticleYear
In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2007, Volume: 65, Issue:3

    Topics: Alkanes; Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Chemistry, Pharmaceutical; Delayed-Action Preparations; Dose-Response Relationship, Drug; Doxorubicin; Drug Carriers; Drug Compounding; Epoxy Compounds; Female; Injections, Intralesional; Lipids; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nanoparticles; Polymers; Stearic Acids; Technology, Pharmaceutical; Time Factors; Triglycerides

2007